These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31420256)

  • 1. Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.
    He Y; Dou H; Gao D; Wang T; Zhang M; Wang H; Li Y
    Bioorg Med Chem; 2019 Oct; 27(19):115015. PubMed ID: 31420256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4.
    Gao DD; Dou HX; Su HX; Zhang MM; Wang T; Liu QF; Cai HY; Ding HP; Yang Z; Zhu WL; Xu YC; Wang HY; Li YX
    Eur J Med Chem; 2018 Jun; 154():44-59. PubMed ID: 29775936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors.
    Cai H; Wang T; Yang Z; Xu Z; Wang G; Wang HY; Zhu W; Chen K
    J Chem Inf Model; 2017 Sep; 57(9):2329-2335. PubMed ID: 28810126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.
    Cai H; Liu Q; Gao D; Wang T; Chen T; Yan G; Chen K; Xu Y; Wang H; Li Y; Zhu W
    Eur J Med Chem; 2015 Jan; 90():241-50. PubMed ID: 25461324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of selective, dual fatty acid binding protein 4 and 5 inhibitors.
    Kühne H; Obst-Sander U; Kuhn B; Conte A; Ceccarelli SM; Neidhart W; Rudolph MG; Ottaviani G; Gasser R; So SS; Li S; Zhang X; Gao L; Myers M
    Bioorg Med Chem Lett; 2016 Oct; 26(20):5092-5097. PubMed ID: 27658368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Dynamics Exploration of Selectivity of Dual Inhibitors 5M7, 65X, and 65Z toward Fatty Acid Binding Proteins 4 and 5.
    Yan F; Liu X; Zhang S; Su J; Zhang Q; Chen J
    Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30142969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into ligand binding features of dual FABP4/5 inhibitors by molecular dynamics simulations.
    Wu W; Han L; Wang C; Wen X; Sun H; Yuan H
    J Biomol Struct Dyn; 2019 Nov; 37(18):4790-4800. PubMed ID: 30590992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
    Zhang M; Zhu W; Li Y
    Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.
    Cai HY; Wang T; Zhao JC; Sun P; Yan GR; Ding HP; Li YX; Wang HY; Zhu WL; Chen KX
    Acta Pharmacol Sin; 2013 Nov; 34(11):1397-402. PubMed ID: 24077632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofluorinated probe for PET imaging of fatty acid binding protein 4 in cancer.
    Temma T; Nishigori K; Onoe S; Sampei S; Kimura I; Ono M; Saji H
    Nucl Med Biol; 2015 Feb; 42(2):184-91. PubMed ID: 25457456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR studies on truxillic acid mono esters as a new class of antinociceptive agents targeting fatty acid binding proteins.
    Yan S; Elmes MW; Tong S; Hu K; Awwa M; Teng GYH; Jing Y; Freitag M; Gan Q; Clement T; Wei L; Sweeney JM; Joseph OM; Che J; Carbonetti GS; Wang L; Bogdan DM; Falcone J; Smietalo N; Zhou Y; Ralph B; Hsu HC; Li H; Rizzo RC; Deutsch DG; Kaczocha M; Ojima I
    Eur J Med Chem; 2018 Jun; 154():233-252. PubMed ID: 29803996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of FABP4/5 inhibitors with potential therapeutic effect on type 2 Diabetes Mellitus.
    He YL; Chen MT; Wang T; Zhang MM; Li YX; Wang HY; Ding N
    Eur J Med Chem; 2021 Nov; 224():113720. PubMed ID: 34332399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based design of potent FABP4 inhibitors with high selectivity against FABP3.
    Chen G; Xie H; You M; Liu J; Shao Q; Li M; Su H; Xu Y
    Eur J Med Chem; 2024 Jan; 264():115984. PubMed ID: 38043490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of potent, selective and orally bioavailable biphenyl scaffold as FABP4 inhibitors for anti-inflammation.
    He Y; Li S; Zhu Y; Wang Y; Chen Y; Zhang D; Wang H; Li Y
    Eur J Med Chem; 2023 May; 253():115319. PubMed ID: 37037141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of BMS-309403-related compounds, including [¹⁴C]BMS-309403, a radioligand for adipocyte fatty acid binding protein.
    Okada T; Hiromura M; Otsuka M; Enomoto S; Miyachi H
    Chem Pharm Bull (Tokyo); 2012; 60(1):164-8. PubMed ID: 22223390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual role of fatty acid-binding protein 5 on endothelial cell fate: a potential link between lipid metabolism and angiogenic responses.
    Yu CW; Liang X; Lipsky S; Karaaslan C; Kozakewich H; Hotamisligil GS; Bischoff J; Cataltepe S
    Angiogenesis; 2016 Jan; 19(1):95-106. PubMed ID: 26625874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FABP4 is secreted from adipocytes by adenyl cyclase-PKA- and guanylyl cyclase-PKG-dependent lipolytic mechanisms.
    Mita T; Furuhashi M; Hiramitsu S; Ishii J; Hoshina K; Ishimura S; Fuseya T; Watanabe Y; Tanaka M; Ohno K; Akasaka H; Ohnishi H; Yoshida H; Saitoh S; Shimamoto K; Miura T
    Obesity (Silver Spring); 2015 Feb; 23(2):359-67. PubMed ID: 25521833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of Fragment Binding Poses Leading to Efficient Discovery of Highly Potent and Orally Effective Inhibitors of FABP4 for Anti-inflammation.
    Su H; Zou Y; Chen G; Dou H; Xie H; Yuan X; Zhang X; Zhang N; Li M; Xu Y
    J Med Chem; 2020 Apr; 63(8):4090-4106. PubMed ID: 32202425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.